New developments in pharmaceutical treatments for cystic fibrosis.
Hartmut
H
Grasemann
D000818:Animals; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000378:metabolism*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000378:metabolism*; D015507:Drugs, Investigational / Q000627:therapeutic use*; D006801:Humans
D015507:Drugs, Investigational; D019005:Cystic Fibrosis Transmembrane Conductance Regulator